相关实验视频
Updated: Jul 8, 2026

07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
固体瘤中抗癌疗法诱导的周围神经病变:诊断,机制和治疗策略
Jiahong Jiang1, Luying Zhan2, Boyang Jiang3
1Cancer Center, Department of Medical Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Cancer letters
|March 28, 2025
概括
抗癌疗法诱导的周围神经病变 (PN) 是癌症治疗的常见副作用. 本综述涵盖了PN诊断,机制和神经保护策略,强调了有限的治疗选择.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 周围神经病变 (PN) 是固体瘤抗癌治疗中的常见不良事件.
- 晚期瘤的发病率和严重程度取决于药物类别,累积剂量和患者的敏感性.
- 由于缺乏特定的生物标志物和成像测试,目前PN的诊断标准尚不清楚.
研究的目的:
- 要总结当前对抗癌疗法诱导的周围神经病变 (PN) 的理解.
- 审查PN的诊断方法,潜在机制和神经保护策略.
- 讨论潜在的PN干预治疗方法.
主要方法:
- 对抗癌症治疗诱导的外围神经病变研究的文献综述.
- 综合有关PN诊断,机制和管理的信息.
- 讨论当前和潜在的未来治疗干预措施.
主要成果:
- 抗癌疗法经常导致外围神经病变 (PN),发生率和严重程度各不相同.
- PN的机制包括直接的神经毒性,线粒体功能障碍和轴突运输受损.
- 对PN的有效治疗方法有限,大多数专注于症状管理而不是疾病逆转.
结论:
- 抗癌疗法诱导的周围神经病变在癌症治疗中提出了重大挑战.
- 需要进一步的研究来澄清诊断标准和开发有效的治疗方法.
- 神经保护策略和新型干预措施对于管理PN至关重要.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...

